Vimarsana
Biggest News Aggregation in the World

Harriet Ullman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Harriet Ullman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Harriet Ullman Today - Breaking & Trending Today

LaVoieHealthScience | O'Dwyer's PR Firms Directory - Vimarsana News

LaVoieHealthScience | O'Dwyer's PR Firms Directory

Premier database and directory of PR firms & public relations agencies. Find the firm that best suits your needs.

Outlook Therapeutics® Announces Strategic Organizational Realignment - Vimarsana News

Outlook Therapeutics® Announces Strategic Organizational Realignment

Realignment focused on supporting ONS-5010 U.S. and EU regulatory and commercial prioritiesContinued progress toward commencement of additional adequate and well-controlled study to support the...

Outlook Therapeutics® Adds Global Commercial Expertise with Appointment of Jedd Comiskey as Senior VP - Vimarsana News

Outlook Therapeutics® Adds Global Commercial Expertise with Appointment of Jedd Comiskey as Senior VP

ISELIN, N.J., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve FDA approval for the first ophthalmic formulation of bevacizumab for the treatment of retinal diseases, today announced the appointment of Jedd Comiskey as Senior VP – Head of Europe. Mr. Comiskey has a successful track record in the planning, organization and execution of product launches. Over the course of his career, he has demonstrated innovative, solutio

Source: yahoo.com
FDA Grants Breakthrough Device Status to Toku's Patented Cardiovascular Risk AI (CLAiR) Platform - Vimarsana News

FDA Grants Breakthrough Device Status to Toku's Patented Cardiovascular Risk AI (CLAiR) Platform

Press Release Toku, Inc., a commercial medical device company specializing in imaging technology and AI, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to its patented CLAiR technology. The CLAiR platform, if…

Outlook Therapeutics® to Present at Guggenheim's 5th Annual - Vimarsana News

Outlook Therapeutics® to Present at Guggenheim's 5th Annual

Live audio webcast fireside chat on Tuesday, November 7th at 1:50 PM ET...